Mark Walker

1.6k total citations
17 papers, 1.2k citations indexed

About

Mark Walker is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Mark Walker has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Mark Walker's work include DNA Repair Mechanisms (5 papers), Microtubule and mitosis dynamics (4 papers) and Cancer-related Molecular Pathways (3 papers). Mark Walker is often cited by papers focused on DNA Repair Mechanisms (5 papers), Microtubule and mitosis dynamics (4 papers) and Cancer-related Molecular Pathways (3 papers). Mark Walker collaborates with scholars based in United Kingdom, United States and Australia. Mark Walker's co-authors include David A. Gillespie, Elizabeth J. Black, George Zachos, Mary T. Scott, Myriam Gorospe, Stefanie Galbán, Justin D. Blethrow, Kotb Abdelmohsen, R Pullmann and Xiaoling Yang and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Diabetes.

In The Last Decade

Mark Walker

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Walker United Kingdom 14 900 277 272 154 145 17 1.2k
Cynthia S.W. Ho Canada 9 675 0.8× 92 0.3× 271 1.0× 89 0.6× 191 1.3× 9 1.0k
Jun Sunayama Japan 10 1.2k 1.3× 170 0.6× 305 1.1× 241 1.6× 36 0.2× 12 1.5k
Fulvio Chiacchiera Italy 18 1.0k 1.1× 74 0.3× 205 0.8× 222 1.4× 85 0.6× 26 1.2k
Delphine Lissa United States 16 519 0.6× 125 0.5× 278 1.0× 167 1.1× 42 0.3× 22 877
Michael K. Connor Canada 19 1.2k 1.4× 227 0.8× 575 2.1× 182 1.2× 18 0.1× 31 1.6k
Dennis Sohn Germany 16 739 0.8× 89 0.3× 344 1.3× 160 1.0× 27 0.2× 24 1.1k
Yvette Bultsma United Kingdom 10 1.1k 1.2× 299 1.1× 231 0.8× 97 0.6× 691 4.8× 11 1.8k
Huadong Pei United States 11 724 0.8× 94 0.3× 309 1.1× 205 1.3× 47 0.3× 16 1.0k
Kazuyuki Yamagata Japan 14 995 1.1× 70 0.3× 258 0.9× 105 0.7× 52 0.4× 25 1.4k
Lora W. Forman United States 14 523 0.6× 46 0.2× 158 0.6× 114 0.7× 111 0.8× 19 743

Countries citing papers authored by Mark Walker

Since Specialization
Citations

This map shows the geographic impact of Mark Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Walker more than expected).

Fields of papers citing papers by Mark Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Walker. The network helps show where Mark Walker may publish in the future.

Co-authorship network of co-authors of Mark Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Walker. A scholar is included among the top collaborators of Mark Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Walker. Mark Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xu, Ning, Silvana Libertini, Elizabeth J. Black, et al.. (2011). Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage. Oncogene. 31(9). 1086–1094. 29 indexed citations
2.
Walker, Mark, et al.. (2009). Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene. 28(24). 2314–2323. 62 indexed citations
3.
Abdelmohsen, Kotb, R Pullmann, Ashish Lal, et al.. (2007). Phosphorylation of HuR by Chk2 Regulates SIRT1 Expression. Molecular Cell. 25(4). 543–557. 454 indexed citations
4.
Zachos, George, Elizabeth J. Black, Mark Walker, et al.. (2007). Chk1 Is Required for Spindle Checkpoint Function. Developmental Cell. 12(2). 247–260. 190 indexed citations
5.
Walker, Mark, et al.. (2007). UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation. FEBS Journal. 274(15). 3960–3971. 23 indexed citations
6.
Bourke, Emer, Helen Dodson, Andreas Merdes, et al.. (2007). DNA damage induces Chk1‐dependent centrosome amplification. EMBO Reports. 8(6). 603–609. 95 indexed citations
7.
Gillespie, David A. & Mark Walker. (2006). Mitotic index determination by flow cytometry. Sub-cellular biochemistry. 40. 355–358. 5 indexed citations
8.
Robinson, Helen M.R., Robert H. Jones, Mark Walker, et al.. (2006). Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil. Oncogene. 25(39). 5359–5369. 43 indexed citations
9.
Black, Elizabeth J., Mark Walker, William Clark, Ann MacLaren, & David A. Gillespie. (2002). Cell transformation by v-Jun deactivates ERK MAP kinase signalling. Oncogene. 21(42). 6540–6548. 14 indexed citations
10.
Brouillet, Jean‐Paul, Anna Kilbey, Ruth Fulton, et al.. (2001). Evi-1 Transforming and Repressor Activities Are Mediated by CtBP Co-repressor Proteins. Journal of Biological Chemistry. 276(28). 25834–25840. 79 indexed citations
11.
Bartholomew, Chris, et al.. (1997). The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene. 14(5). 569–577. 64 indexed citations
12.
Lanfear, Jerry, Janis Fleming, Mark Walker, & Paul R. Harrison. (1993). Different patterns of regulation of the genes encoding the closely related 56 kDa selenium- and acetaminophen-binding proteins in normal tissues and during carcinogenesis. Carcinogenesis. 14(3). 335–340. 68 indexed citations
13.
Walker, Mark, et al.. (1987). Immunochemical detection of cell cycle synchronization in a human erythroleukemia cell line, K562.. Journal of Histochemistry & Cytochemistry. 35(10). 1143–1148. 2 indexed citations
14.
Smith, Graeme C., et al.. (1982). Further studies on the effects of intravenously administered 6-hydroxydopamine on the median eminence of the rat. Brain Research. 234(1). 101–110. 15 indexed citations
15.
Körner, Paul, et al.. (1978). Cardiovascular and behavioral effects of intracisternal 6-hydroxydopamine in the rabbit. European Journal of Pharmacology. 53(1). 83–93. 29 indexed citations
16.
Malaisse, Willy, et al.. (1976). Effect of l-methyl-l-nitrosourea and streptozotocin on glucose-induced insulin secretion by isolated islets of Langerhans. Diabetologia. 12(3). 207–209. 5 indexed citations
17.
Malaisse, Willy, et al.. (1971). Effect of Streptozotocin on Glucose-induced Insulin Secretion by Isolated Islets of Langerhans. Diabetes. 20(8). 513–518. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026